
Pressure relieved on AZ as details of Chinese probe emerge
AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.
Newsletters and Deep Dive digital magazine
AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.
Nearly 700,000 women will be recruited into an NHS trial of AI tools for breast cancer screening, in the hope of relieving pressure on radiologists.
Pfizer's Braftovi - just approved by the FDA as a first-line treatment for colorectal cancer based on response data - also extends patient survival.
Company Name:Daiichi Sankyo Representative Director, Executive Chairperson & CEO
Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.
Editor's Picks
Newsletters and Deep Dive
digital magazine